ARS Pharmaceuticals Inc.
(SPRY)
undefined
undefined%
At close: undefined
12.05
1.13%
After-hours Dec 13, 2024, 07:09 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -2.40 | -2.51 | -2.37 | -377.48 | -8.62 | -11.76 |
| PS Ratio | 4348.17 | 64.75 | 8.73 | 22.54 | 0.00 | 0.00 |
| PB Ratio | 0.57 | 0.31 | -1.54 | -28.61 | -36.89 | 11.36 |
| P/FCF Ratio | -2.19 | -2.12 | -2.73 | 49.30 | -10.88 | -11.93 |
| P/OCF Ratio | -2.20 | -2.13 | -2.74 | 44.32 | -10.94 | -12.25 |
| OCF/S Ratio | -493.88 | -7.61 | -0.80 | 0.13 | 0.00 | 0.00 |
| Debt / Equity Ratio | 0.00 | 0.00 | -0.07 | -0.18 | -0.55 | 0.05 |
| Quick Ratio | 24.23 | 12.80 | 2.06 | 0.88 | 0.15 | 1.01 |
| Current Ratio | 24.23 | 12.75 | 1.85 | 0.80 | 0.15 | 1.01 |
| Asset Turnover | 0.00 | 0.00 | 0.09 | 0.68 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | -45.88 | -4.04 | 0.00 | 0.00 |
| Return on Equity (ROE) | -23.56% | -12.46% | 64.74% | 7.58% | 427.75% | -96.60% |
| Return on Assets (ROA) | -23.31% | -12.08% | -32.94% | -4.03% | -153.17% | -63.81% |
| Return on Capital (ROIC) | -29.26% | -12.87% | -36.53% | -2.58% | 1056.03% | -81.77% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit Margin | -35.83% | -304.03% | -67.05% | 5.28% | 0.00% | 0.00% |
| Net Profit Margin | -45304.17% | -645.67% | -91.91% | -1.49% | 0.00% | 0.00% |